SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024457
Filing Date
2021-06-17
Accepted
2021-06-17 17:06:58
Documents
2
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1551
2 EX-24 DOCUMENT attachment1.htm EX-24 3891
  Complete submission text file 0000899243-21-024457.txt   6811
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Murray Joshua M. (Reporting) CIK: 0001867952 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 211025651